The global Companion Diagnostic Tests market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Companion Diagnostic Tests volume and value at global level, regional level and company level. From a global perspective, this report represents overall Companion Diagnostic Tests market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Companion Diagnostic Tests in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Companion Diagnostic Tests manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
F. Hoffman LA Roche Ltd.
QIAGEN, Illumina, Inc.
Abbott
Agilent Technologies, Inc.
Genomic Health, Inc.
BioMerieux SA, BioGenex
AGENDIA NV
Siemens Healthcare GmBH
Thermo Fisher Scientific, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Protein Detection
DNA Detection
Hybridization
Biomarker
Others

Segment by Application
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes